Unhealthy Politics: The Battle over Evidence-Based Medicine
| Author | : | |
| Rating | : | 4.62 (949 Votes) |
| Asin | : | B06ZZGWQ4V |
| Format Type | : | |
| Number of Pages | : | 591 Pages |
| Publish Date | : | 2016-09-28 |
| Language | : | English |
DESCRIPTION:
Alan S. Patashnik is the Julis-Rabinowitz Professor of Public Policy and Political Science at Brown University. Eric M. Conor M. and Dorathea S. Dowling is associate professor of political science at the University of Mississippi. His books include Field Experiments. He is the coauthor of Super PAC!. Dilley Professor of Political Science at Yale University. His books include Reforms
How partisanship, polarization, and medical authority stand in the way of evidence-based medicineThe U.S. Unhealthy Politics sheds new light on why the government’s response to this troubling situation has been so inadequate, and why efforts to improve the evidence base of U.S. medical system is touted as the most advanced in the world, yet many common treatments are not based on sound science. Treatments can go into widespread use before they are rigorously evaluated, and every year patients are harmed because they receive too many procedures—and too few treatments that really work. It also proposes sensible solutions that can lead to better, more efficient health care for all of us.Unhealthy Politics offers vital insights not only into health policy but also into the limits of scienc
This is a magnificent book. At the same time, much care proven to genuinely work is not reliably delivered to the patients who need it most. It will be widely read."--Michael K. In principle, comparative effectiveness research (CER) provides tools to do better. Original, persuasive, and essential reading."--Jonathan Oberlander, author of The Political Life of Medicare"Much of the $3 trillion America spends on health care is expended on care of little demonstrated value. Following their advice might save us hundreds of billions."--Daniel Carpenter, Harvard University, author of Reputation and Power: Organizational Image and Pharmaceutical Regulation at